# Compassionate Use of Omegaven in the Treatment of Parenteral Nutrition Induced Hepatic Injury

> **NCT02010034** · NA · COMPLETED · sponsor: **Children's Medical Center Dallas** · enrollment: 15 (estimated)

## Conditions studied

- Liver Disease
- Impaired Liver Function
- Parenteral Nutrition Associated Liver Disease

## Interventions

- **DRUG:** Omegaven

## Key facts

- **NCT ID:** NCT02010034
- **Lead sponsor:** Children's Medical Center Dallas
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2019-02-05
- **Final completion:** 2019-02-05
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2019-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02010034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02010034, "Compassionate Use of Omegaven in the Treatment of Parenteral Nutrition Induced Hepatic Injury". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02010034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*